CH Biotech R&D Co., Ltd.
CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.
Market Cap & Net Worth: CH Biotech R&D Co., Ltd. (6534)
CH Biotech R&D Co., Ltd. (TW:6534) has a market capitalization of $260.37 Million (NT$8.61 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #18520 globally and #858 in its home market, demonstrating a 0.72% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CH Biotech R&D Co., Ltd.'s stock price NT$83.80 by its total outstanding shares 102800000 (102.80 Million).
CH Biotech R&D Co., Ltd. Market Cap History: 2025 to 2026
CH Biotech R&D Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $279.63 Million to $260.37 Million (0.00% CAGR).
CH Biotech R&D Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CH Biotech R&D Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6534 by Market Capitalization
Companies near CH Biotech R&D Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to CH Biotech R&D Co., Ltd. by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
CH Biotech R&D Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, CH Biotech R&D Co., Ltd.'s market cap moved from $279.63 Million to $ 260.37 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$260.37 Million | -6.89% |
| 2025 | NT$279.63 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CH Biotech R&D Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $260.37 Million USD |
| MoneyControl | $260.37 Million USD |
| MarketWatch | $260.37 Million USD |
| marketcap.company | $260.37 Million USD |
| Reuters | $260.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.